Setting our AdipoSIGHTS on Stem Cells in Pharmacogenomics.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30735647.
- Also identified by DOI 10.1016/j.stem.2019.01.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a recent study published in Cell Stem Cell, Hu et al. (2019) used human adipose stem cell-derived adipocytes to demonstrate that genetic variation predicts anti-diabetic response to thiazolidinediones (TZDs) by modulating PPARγ binding.
Medical subject headings
- Pharmacogenetics
- Thiazolidinediones